Literature DB >> 25176558

Cardiovascular disease prevention.

G Van Camp.   

Abstract

Cardiovascular diseases remain the first killer in the Western countries. Equivalent contributions of prevention initiatives, pharmaceutical developments and technological improvements have led to an important success in the reduction of mortality related to cardiovascular diseases in some of the countries of the Western world. However, increase in life expectance, incomplete adherence to guidelines, difficulties in convincing governments and the population to support and adhere to prevention measures make that the burden of cardiovascular diseases is still extremely high. This review gives a restricted summary of the most important prevention guidelines supported by the European Society of Cardiology. It also illustrates the still very incomplete adherence to these guidelines in the different European countries as published in the EUROASPIRE surveys.

Entities:  

Keywords:  Cardiology,; Cardiovascular diseases; Prevention,

Mesh:

Year:  2014        PMID: 25176558     DOI: 10.1179/2295333714Y.0000000069

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  18 in total

Review 1.  Molecular and Biological Functions of Quercetin as a Natural Solution for Cardiovascular Disease Prevention and Treatment.

Authors:  Liaosadat Mirsafaei; Željko Reiner; Rana Shafabakhsh; Zatollah Asemi
Journal:  Plant Foods Hum Nutr       Date:  2020-09       Impact factor: 3.921

2.  Machine learning-based diagnosis and risk factor analysis of cardiocerebrovascular disease based on KNHANES.

Authors:  Taeseob Oh; Dongkyun Kim; Siryeol Lee; Changwon Won; Sunyoung Kim; Ji-Soo Yang; Junghwa Yu; Byungsung Kim; Joohyun Lee
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

Review 3.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

4.  Subretinal Drusenoid Deposits and Lower Serum High-Density Lipoprotein Cholesterol Levels Possess Latent Relation to Cardiovascular Disease and Can Be a Feasible Predictor.

Authors:  Changsen Liang; Ning Wang
Journal:  Comput Math Methods Med       Date:  2022-07-01       Impact factor: 2.809

Review 5.  The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases.

Authors:  Wenhua Jiang; Manling Liu; Chunhu Gu; Heng Ma
Journal:  Cardiovasc Toxicol       Date:  2020-10-01       Impact factor: 3.231

6.  MiR-467a-5p aggravates myocardial infarction by modulating ZEB1 expression in mice.

Authors:  Wei Huang; Yu Cao; Chenyang Chen; Xi Wu; Zhe Sheng; Anying Li
Journal:  J Mol Histol       Date:  2021-05-17       Impact factor: 2.611

7.  MiR-124 Regulates the Inflammation and Apoptosis in Myocardial Infarction Rats by Targeting STAT3.

Authors:  Xiao-Jing Cheng; Lei Li; Ben-Qiang Xin
Journal:  Cardiovasc Toxicol       Date:  2021-05-26       Impact factor: 3.231

Review 8.  Endothelial Progenitor Cell-Derived Extracellular Vesicles: Potential Therapeutic Application in Tissue Repair and Regeneration.

Authors:  Sonia Terriaca; Elena Fiorelli; Maria Giovanna Scioli; Giulia Fabbri; Gabriele Storti; Valerio Cervelli; Augusto Orlandi
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

Review 9.  Recent Advances of Cell Membrane Coated Nanoparticles in Treating Cardiovascular Disorders.

Authors:  Chaojie Zhu; Junkai Ma; Zhiheng Ji; Jie Shen; Qiwen Wang
Journal:  Molecules       Date:  2021-06-05       Impact factor: 4.411

Review 10.  Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.

Authors:  Rajasekharreddy Pala; V T Anju; Madhu Dyavaiah; Siddhardha Busi; Surya M Nauli
Journal:  Int J Nanomedicine       Date:  2020-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.